Biomerica Inc.

The Newport Beach developer and manufacturer of medical diagnostic products reported net income of $103,681, or 3 cents a share, for the second quarter ended Nov. 30, which was 9% higher than the $95,188, or 3 cents a share, for the same period last year. Revenue was unchanged at $2.3 million. For the six-month period, net income rose 48% to $230,885, or 7 cents a share, up from $155,493, or 5 cents a share, for the first half last year. Revenue remained at $4.6 million.